BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15548640)

  • 21. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
    Chiu WA; White P
    Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory exposure to components of water-miscible metalworking fluids.
    Suuronen K; Henriks-Eckerman ML; Riala R; Tuomi T
    Ann Occup Hyg; 2008 Oct; 52(7):607-14. PubMed ID: 18678881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of non-occupational sources on the levels of biomarkers of internal dose for use in biological monitoring of occupational exposure to extremely low concentrations of benzene].
    Lovreglio P; Cancanelli G; Barbieri A; Sabatini L; D'Errico MN; Scicolone L; Ghitti R; Violante FS; Apostoli P; Soleo L
    G Ital Med Lav Ergon; 2010; 32(1):49-58. PubMed ID: 20464977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhalation risk assessment of exposure to the selected volatile organic compounds (VOCs) emitted from the facilities of a steel plant.
    Chiang HL; Lin WH; Lai JS; Wang WC
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2010 Sep; 45(11):1397-405. PubMed ID: 20665324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs).
    DeJongh J; Verhaar HJ; Hermens JL
    Toxicol Sci; 1998 Sep; 45(1):26-32. PubMed ID: 9848107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An experimental study to investigate the feasibility to classify paints according to neurotoxicological risks: occupational air requirement (OAR) and indoor use of alkyd paints.
    Brouwer DH; de Pater NA; Zomer C; Lurvink MW; van Hemmen JJ
    Ann Occup Hyg; 2005 Jul; 49(5):443-51. PubMed ID: 15790614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on monitoring index of individual exposure dose of volatile organic compounds in environment].
    Feng B; Cui J; Hao S
    Wei Sheng Yan Jiu; 2003 Nov; 32(6):556-8. PubMed ID: 14963902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A search for thresholds and other nonlinearities in the relationship between hexavalent chromium and lung cancer.
    Park RM; Stayner LT
    Risk Anal; 2006 Feb; 26(1):79-88. PubMed ID: 16492182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
    Valcke M; Haddad S
    J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Passive personal sampler for exposure to low concentration of volatile organic compounds].
    Xu D; Cui J; Wang B
    Wei Sheng Yan Jiu; 1999 Jul; 28(4):246-8. PubMed ID: 11938990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personal, indoor, and outdoor VOC exposures in a probability sample of children.
    Adgate JL; Eberly LE; Stroebel C; Pellizzari ED; Sexton K
    J Expo Anal Environ Epidemiol; 2004; 14 Suppl 1():S4-S13. PubMed ID: 15118740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans.
    Sweeney LM; Gargas ML; Strother DE; Kedderis GL
    Toxicol Sci; 2003 Jan; 71(1):27-40. PubMed ID: 12520073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological exposure indicators: quantification of biological variability using toxicokinetic modeling.
    Truchon G; Tardif R; Droz PO; Charest-Tardif G; Pierrehumbert G
    J Occup Environ Hyg; 2006 Mar; 3(3):137-43. PubMed ID: 16464817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of biological and environmental variabilities on biological monitoring--an approach using toxicokinetic models.
    Berthet A; de Batz A; Tardif R; Charest-Tardif G; Truchon G; Vernez D; Droz PO
    J Occup Environ Hyg; 2010 Mar; 7(3):177-84. PubMed ID: 20063230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzene toxicokinetics in humans: exposure of bone marrow to metabolites.
    Watanabe KH; Bois FY; Daisey JM; Auslander DM; Spear RC
    Occup Environ Med; 1994 Jun; 51(6):414-20. PubMed ID: 8044234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and validation of a pharmacokinetic model for benzene.
    Sinclair GC; Gray CN; Sherwood RJ
    Am Ind Hyg Assoc J; 1999; 60(2):249-58. PubMed ID: 10222576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.